Laboratory Testing for Endocrine Hypertension: Current and Future Perspectives
Clinical Chemistry · 02.05.2024 · 70 (5) · 709-726
DOI: 10.1093/clinchem/hvae022 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Chemistry, online erschienen am 14.03.2024. Verfasst von Louisiane Courcelles und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Cliniques Universitaires St-Luc and Université Catholique de Louvain, Brussels, Belgium. Hauptthemen laut MEDLINE: Hypertension, Biomarkers. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 75 Literaturangaben.
Abstract (Originalsprache)
Background Secondary hypertension (SH) is a form of high blood pressure caused by an identifiable underlying condition. Although, it accounts for a small fraction of the overall hypertensive population, detection and management of SH is of utmost importance, because SH phenotypes carry a high cardiovascular risk and can possibly be cured by timely treatment. Content This review focuses on the endocrine causes of SH, such as primary aldosteronism, Cushing syndrome, thyroid disease, pheochromocytoma and paraganglioma, acromegaly, and rare monogenic forms. It discusses current biomarkers, analytical methods, and diagnostic strategies, highlighting advantages and limitations of each approach. It also explores the emerging -omics technologies that can provide a comprehensive and multidimensional assessment of SH and its underlying mechanisms. Summary Endocrine SH is a heterogeneous and complex condition that requires proper screening and confirmatory tests to avoid diagnostic delays and improve patient outcomes. Careful biomarker interpretation is essential due to potential interferences, variability, and method-dependent differences. Liquid chromatography–tandem mass spectrometry is a superior method for measuring low-concentration hormones and metabolites involved in SH, but it requires expertise. Omics approaches have great potential to identify novel biomarkers, pathways, and targets for SH diagnosis and treatment, especially considering its multifactorial nature.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Cliniques Universitaires St-Luc and Université Catholique de Louvain, Brussels, Belgium.
- Department of Internal Medicine, Rheumatology, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
- Louvain centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
- AP-HP, Hôpital Avicenne, Centre d'Excellence Européen en Hypertension Artérielle, Service de Médecine Interne, Paris, France.
- INSERM UMR 942 MASCOT, Paris 13-Université Paris Nord, Bobigny, France.
- FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), CHRU de Nancy - Hôpitaux de Brabois, Vandoeuvre-lès-Nancy, France.
ORCID-Profile: Reinhold Kreutz
Zitieren
APA
Courcelles, L., Stoenoiu, M., Haufroid, V., Lopez-Sublet, M., Boland, L., Wauthier, L., Beauloye, C., Maiter, D., Januszewicz, A., Kreutz, R., Persu, A., & Gruson, D. (2024). Laboratory Testing for Endocrine Hypertension: Current and Future Perspectives. Clinical Chemistry, 70(5), 709-726. https://doi.org/10.1093/clinchem/hvae022
Vancouver
Courcelles L, Stoenoiu M, Haufroid V, Lopez-Sublet M, Boland L, Wauthier L, et al. Laboratory Testing for Endocrine Hypertension: Current and Future Perspectives. Clinical Chemistry. 2024;70(5):709-726. doi:10.1093/clinchem/hvae022
BibTeX
@article{Courcelles2024,
author = {Courcelles, Louisiane and Stoenoiu, Maria and Haufroid, Vincent and Lopez-Sublet, Marilucy and Boland, Lidvine and Wauthier, Loris and Beauloye, Christophe and Maiter, Dominique and Januszewicz, Andrzej and Kreutz, Reinhold and Persu, Alexandre and Gruson, Damien},
title = {Laboratory Testing for Endocrine Hypertension: Current and Future Perspectives},
journal = {Clinical Chemistry},
year = {2024},
volume = {70},
number = {5},
pages = {709--726},
doi = {10.1093/clinchem/hvae022}
}
EUVIMED